Literature DB >> 12672074

Colonic lamina propria dendritic cells in mice with CD4+ T cell-induced colitis.

Tamara Krajina1, Frank Leithäuser, Peter Möller, Zlatko Trobonjaca, Jörg Reimann.   

Abstract

CD11c(+) (F4/80(-) CD68(-)) dendritic cells (DC) in the colonic lamina propria (cLP) of normal and immunodeficient (RAG1(-/-)) C57BL/6 (B6) mice show high surface expression of MHC class I/II molecules and CD1d, and low surface expression of CD40, CD80, CD86 costimulator molecules. CD4(+) alpha beta T cells from normal or MHC class II-deficient B6 mice transferred into congenic RAG1(-/-) hosts induce a progressive, lethal colitis. Concomitant with colitis development, DC in the inflamed cLP increase in number and up-regulate surface expression of CD1d, MHC class II molecules and CD40, CD80, CD86 costimulator molecules. cLP DC from non-transplanted (healthy) and transplanted (diseased) mice produce similar amounts of IL-12 p70 and IL-10 in response to CD40 signaling, but the inducible IL-12 p40 release is 5-15-fold higher in mice with colitis than in non-transplanted mice. Binding of IL-12 p40 to p19 generates IL-23. Freshly isolated cLP lymphocytes (cLPL) from transplanted, diseased mice express 3-10-fold more p19 transcripts than cLPL from non-transplanted, healthy mice. p19 expression by cLPL is further up-regulated in response to CD40 ligation. Freshly isolated cLP DC from transplanted mice with colitis (but not from non-transplanted controls) stimulate IFN-gamma (but not IL-4 or IL-13) release by co-cultured NKT cells. Incolitis, DC accumulate in the cLP, show an activated surface phenotype, up-regulate IL-12 p40 and p19 expression, and 'spontaneously' stimulate NKT-like cells. cLP DC may be interesting targets for novel therapeutic approaches to modulate mucosal T cell responses in situ.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12672074     DOI: 10.1002/eji.200323518

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  25 in total

1.  Flt3 ligand expands CD103⁺ dendritic cells and FoxP3⁺ T regulatory cells, and attenuates Crohn's-like murine ileitis.

Authors:  Colm B Collins; Carol M Aherne; Eóin N McNamee; Matthew D P Lebsack; Holger Eltzschig; Paul Jedlicka; Jesús Rivera-Nieves
Journal:  Gut       Date:  2011-11-07       Impact factor: 23.059

2.  Production of interleukin (IL)-10 and IL-12 by murine colonic dendritic cells in response to microbial stimuli.

Authors:  R J Rigby; S C Knight; M A Kamm; A J Stagg
Journal:  Clin Exp Immunol       Date:  2005-02       Impact factor: 4.330

Review 3.  Immunopathogenesis of IBD: insufficient suppressor function in the gut?

Authors:  I L Huibregtse; A U van Lent; S J H van Deventer
Journal:  Gut       Date:  2006-10-17       Impact factor: 23.059

4.  Proinflammatory cytokine synthesis by mucosal fibroblasts from mouse colitis is enhanced by interferon-gamma-mediated up-regulation of CD40 signalling.

Authors:  T De L Karlson; C V Whiting; P W Bland
Journal:  Clin Exp Immunol       Date:  2007-02       Impact factor: 4.330

Review 5.  The dendritic cell: its role in intestinal inflammation and relationship with gut bacteria.

Authors:  A J Stagg; A L Hart; S C Knight; M A Kamm
Journal:  Gut       Date:  2003-10       Impact factor: 23.059

6.  Characterization of colonic dendritic cells in normal and colitic mice.

Authors:  Sheena M Cruickshank; Nicholas R English; Peter J Felsburg; Simon R Carding
Journal:  World J Gastroenterol       Date:  2005-10-28       Impact factor: 5.742

Review 7.  Role of mucosal dendritic cells in inflammatory bowel disease.

Authors:  Jan Hendrik Niess
Journal:  World J Gastroenterol       Date:  2008-09-07       Impact factor: 5.742

8.  Exaggerated inflammatory response of primary human myeloid dendritic cells to lipopolysaccharide in patients with inflammatory bowel disease.

Authors:  D C Baumgart; S Thomas; I Przesdzing; D Metzke; C Bielecki; S M Lehmann; S Lehnardt; Y Dörffel; A Sturm; A Scheffold; J Schmitz; A Radbruch
Journal:  Clin Exp Immunol       Date:  2009-09       Impact factor: 4.330

Review 9.  Dendritic cells in intestinal homeostasis and disease.

Authors:  Maria Rescigno; Antonio Di Sabatino
Journal:  J Clin Invest       Date:  2009-09-01       Impact factor: 14.808

Review 10.  Cellular and molecular mechanisms in the two major forms of inflammatory bowel disease.

Authors:  Laszlo Bene; Andras Falus; Noemi Baffy; Andras Kristof Fulop
Journal:  Pathol Oncol Res       Date:  2011-06-17       Impact factor: 3.201

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.